GlassScriptPhysician profile
Jason M Scopp
NPI 1417023326
$637,400.51
in general payments reported to CMS, 2019-2025
11 companies · $170K in 2025
The $170K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $73K · 2021: $104K · 2022: $89K · 2023: $41K · 2024: $58K · 2025: $170K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $215K · Consulting Fee: $33K · Travel and Lodging: $17K · Food and Beverage: $3,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $215,014.69 |
| Consulting Fee | $32,560.00 |
| Travel and Lodging | $16,566.51 |
| Food and Beverage | $3,970.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $634,127.65 | 2019-2025 | Arthrex |
| Supreme Orthopedic Systems, LLC | $1,793.40 | 2019-2024 | |
| Vericel Corporation | $575.00 | 2019 | |
| Stryker Corporation | $517.28 | 2025 | Procinch |
| Native Surgical, LLC | $179.68 | 2025 | |
| Evolution Surgical, INC | $102.30 | 2024 | |
| Smith+Nephew, INC. | $75.00 | 2024-2025 | Clear-Trac, Accu-Pass, Cap-Fix |
| Heron Therapeutics, INC. | $19.35 | 2025 | Zynrelef |
| Aesculap Biologics, LLC | $10.85 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Scopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.